NCT06780124View on ClinicalTrials.gov

Сlinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of ZE63-0302 in Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

April 12, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Healthy
Interventions
DRUG

ZE63-0302 or placebo

The participants will receive ZE63-0302 or placebo

Trial Locations (1)

WA6009

RECRUITING

Linear Clinical Research Ltd, Perth

Sponsors
All Listed Sponsors
lead

Eilean Therapeutics

INDUSTRY

NCT06780124 - Сlinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of ZE63-0302 in Healthy Volunteers | Biotech Hunter | Biotech Hunter